Attachment_H_-_Sample_Client_Letter_for_Past_Performance.docx

SAMPLE CLIENT LETTER

Dear Client, We are currently responding to Solicitation Number FDA-18-223-SOL-1196210 for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Biological Products.

The FDA placed emphasis on past performance as a key source selection factor and requiring that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.

Therefore, enclosed is a Past Performance Evaluation Questionnaire for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration at the following address no later than 1:00 PM Central Time on July 25, 2018:

Food and Drug Administration Division of Acquisition Programs Field Operation Branch, HFT-320 Attn: Nick Sartain, Contract Specialist 3900 NCTR Road, Bldg 50, Rm 422 Jefferson, AR 72079

The questionnaire can be emailed to nick.sartain@fda.hhs.gov. Again, the questionnaire must be submitted to Mr. Sartain not later than 1:00 PM Central Time on July 25, 2018.

If you have questions regarding the attached questionnaire, or require assistance, please contact Nick Sartain, FDA Contract Specialist at 870-543-7370 or nick.sartain@fda.hhs.gov.

We thank you for your prompt response in this matter.

Sincerely, {Offering Entity}